OCUL logo

Ocular Therapeutix (OCUL) Cash From Investing

Annual CFI

-$1.29 M
+$4.80 M+78.84%

December 31, 2024


Summary


Performance

OCUL Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherOCULcash flowmetrics:

Quarterly CFI

-$202.00 K
-$113.00 K-126.97%

December 31, 2024


Summary


Performance

OCUL Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherOCULcash flowmetrics:

TTM CFI

-$1.29 M
+$257.00 K+16.63%

December 31, 2024


Summary


Performance

OCUL TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherOCULcash flowmetrics:

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

OCUL Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+78.8%-127.0%+16.6%
3 y3 years-7.9%+68.0%-7.9%
5 y5 years+42.5%+66.4%+42.5%

OCUL Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-7.9%+78.8%-127.0%+94.0%-7.9%+84.5%
5 y5-year-53.1%+78.8%-127.0%+94.0%-71.7%+84.5%
alltimeall time-103.5%+96.7%-100.8%+99.5%-102.8%+98.3%

Ocular Therapeutix Cash From Investing History

DateAnnualQuarterlyTTM
Dec 2024
-$1.29 M(-78.8%)
-$202.00 K(+127.0%)
-$1.29 M(-16.6%)
Sep 2024
-
-$89.00 K(-88.0%)
-$1.54 M(-9.9%)
Jun 2024
-
-$742.00 K(+191.0%)
-$1.72 M(-42.1%)
Mar 2024
-
-$255.00 K(-44.4%)
-$2.96 M(-51.3%)
Dec 2023
-$6.09 M(+63.8%)
-$459.00 K(+77.2%)
-$6.09 M(-21.7%)
Sep 2023
-
-$259.00 K(-87.0%)
-$7.78 M(-6.4%)
Jun 2023
-
-$1.99 M(-41.1%)
-$8.31 M(+21.9%)
Mar 2023
-
-$3.38 M(+57.2%)
-$6.82 M(+83.5%)
Dec 2022
-$3.71 M(+211.1%)
-$2.15 M(+170.8%)
-$3.71 M(+69.2%)
Sep 2022
-
-$794.00 K(+60.4%)
-$2.20 M(+30.9%)
Jun 2022
-
-$495.00 K(+79.3%)
-$1.68 M(+27.9%)
Mar 2022
-
-$276.00 K(-56.3%)
-$1.31 M(+9.9%)
Dec 2021
-$1.19 M(+42.0%)
-$631.00 K(+128.6%)
-$1.19 M(+46.3%)
Sep 2021
-
-$276.00 K(+114.0%)
-$816.00 K(+8.2%)
Jun 2021
-
-$129.00 K(-18.4%)
-$754.00 K(+0.5%)
Mar 2021
-
-$158.00 K(-37.5%)
-$750.00 K(-10.8%)
Dec 2020
-$841.00 K(-62.4%)
-$253.00 K(+18.2%)
-$841.00 K(-29.3%)
Sep 2020
-
-$214.00 K(+71.2%)
-$1.19 M(-14.7%)
Jun 2020
-
-$125.00 K(-49.8%)
-$1.39 M(-20.9%)
Mar 2020
-
-$249.00 K(-58.6%)
-$1.76 M(-21.3%)
Dec 2019
-$2.24 M(+18.5%)
-$601.00 K(+43.4%)
-$2.24 M(+5.8%)
Sep 2019
-
-$419.00 K(-15.0%)
-$2.12 M(-2.5%)
Jun 2019
-
-$493.00 K(-32.0%)
-$2.17 M(-2.8%)
Mar 2019
-
-$725.00 K(+51.4%)
-$2.23 M(+18.2%)
DateAnnualQuarterlyTTM
Dec 2018
-$1.89 M(-107.0%)
-$479.00 K(+1.3%)
-$1.89 M(-4.3%)
Sep 2018
-
-$473.00 K(-14.9%)
-$1.97 M(+271.1%)
Jun 2018
-
-$556.00 K(+45.9%)
-$532.00 K(-102.8%)
Mar 2018
-
-$381.00 K(-32.4%)
$18.73 M(-30.5%)
Dec 2017
$26.95 M(-27.3%)
-$564.00 K(-158.2%)
$26.95 M(+62.0%)
Sep 2017
-
$969.00 K(-94.8%)
$16.64 M(-38.3%)
Jun 2017
-
$18.70 M(+138.4%)
$26.99 M(+34.7%)
Mar 2017
-
$7.85 M(-172.1%)
$20.04 M(-45.9%)
Dec 2016
$37.07 M(-196.1%)
-$10.88 M(-196.1%)
$37.07 M(-19.2%)
Sep 2016
-
$11.32 M(-3.7%)
$45.86 M(+559.2%)
Jun 2016
-
$11.76 M(-52.7%)
$6.96 M(+67.3%)
Mar 2016
-
$24.87 M(-1292.4%)
$4.16 M(-110.8%)
Dec 2015
-$38.57 M(-0.0%)
-$2.09 M(-92.4%)
-$38.57 M(-48.1%)
Sep 2015
-
-$27.59 M(-408.0%)
-$74.25 M(+58.2%)
Jun 2015
-
$8.96 M(-150.2%)
-$46.94 M(-16.4%)
Mar 2015
-
-$17.85 M(-52.7%)
-$56.14 M(+45.5%)
Dec 2014
-$38.59 M(+9870.5%)
-$37.77 M(>+9900.0%)
-$38.59 M(+3664.5%)
Sep 2014
-
-$274.00 K(+10.5%)
-$1.02 M(+19.2%)
Jun 2014
-
-$248.00 K(-16.5%)
-$860.00 K(+29.7%)
Mar 2014
-
-$297.00 K(+44.2%)
-$663.00 K(+71.3%)
Dec 2013
-$387.00 K(-110.1%)
-$206.00 K(+89.0%)
-$387.00 K(+113.8%)
Sep 2013
-
-$109.00 K(+113.7%)
-$181.00 K(+151.4%)
Jun 2013
-
-$51.00 K(+142.9%)
-$72.00 K(+242.9%)
Mar 2013
-
-$21.00 K
-$21.00 K
Dec 2012
$3.81 M
-
-

FAQ

  • What is Ocular Therapeutix annual cash flow from investing activities?
  • What is the all time high annual CFI for Ocular Therapeutix?
  • What is Ocular Therapeutix annual CFI year-on-year change?
  • What is Ocular Therapeutix quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Ocular Therapeutix?
  • What is Ocular Therapeutix quarterly CFI year-on-year change?
  • What is Ocular Therapeutix TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Ocular Therapeutix?
  • What is Ocular Therapeutix TTM CFI year-on-year change?

What is Ocular Therapeutix annual cash flow from investing activities?

The current annual CFI of OCUL is -$1.29 M

What is the all time high annual CFI for Ocular Therapeutix?

Ocular Therapeutix all-time high annual cash flow from investing activities is $37.07 M

What is Ocular Therapeutix annual CFI year-on-year change?

Over the past year, OCUL annual cash flow from investing activities has changed by +$4.80 M (+78.84%)

What is Ocular Therapeutix quarterly cash flow from investing activities?

The current quarterly CFI of OCUL is -$202.00 K

What is the all time high quarterly CFI for Ocular Therapeutix?

Ocular Therapeutix all-time high quarterly cash flow from investing activities is $24.87 M

What is Ocular Therapeutix quarterly CFI year-on-year change?

Over the past year, OCUL quarterly cash flow from investing activities has changed by -$113.00 K (-126.97%)

What is Ocular Therapeutix TTM cash flow from investing activities?

The current TTM CFI of OCUL is -$1.29 M

What is the all time high TTM CFI for Ocular Therapeutix?

Ocular Therapeutix all-time high TTM cash flow from investing activities is $45.86 M

What is Ocular Therapeutix TTM CFI year-on-year change?

Over the past year, OCUL TTM cash flow from investing activities has changed by +$257.00 K (+16.63%)